Renewed fears about the safety of an arthritis drug after a study links it to increased risk of heart attacks.
New Zealand researchers say a re-analysis of older studies on Pfizer’s pain reliever Celebrex shows the drug can raise the risk of suffering a heart attack.
Using data from past Celebrex trials, the study concluded the drug could nearly double the risk of heart attack in patients.
Celebrex is in the same drug family as Vioxx, which was withdrawn from the market last year.
The analysis used data from six studies on Celebrex, involving nearly thirteen-thousand users.